Full Member
Edna Patricia Matta-Camacho
Membership since:
2025
Field of activity:
Degrees:
2012
Doctorate Biological Systems and Organisms
M.Sc. in Biochemistry - 2006
“Structure-Function relationship for the active site of PPII (Pyroglutamyl amino peptidase II) protein bound to its ligand the thyrotropin releasing hormone (TRH)”
National Autonomous University of Mexico (UNAM), Mexico
B.Sc. in Chemistry - 2003
“Production, purification and characterization of polyclonal antibodies against PPII (Pyroglutamyl amino peptidase II) protein, ectoenzyme responsible for the degradation of the thyrotropin releasing hormone (TRH)”
National University of Colombia (UN), Colombia
Publications resulting from Research
1) Antidepressant actions of ketamine engage cell-specific translation via eIF4E.
Aguilar-Valles A, De Gregorio D, Matta-Camacho E, Eslamizade MJ, Khlaifia A, Skaleka A, Lopez-Canul M, Torres-Berrio A, Bermudez S, Rurak GM, Simard S, Salmaso N, Gobbi G, Lacaille JC, Sonenberg N.
Nature. 2021,
2) Maternal Immune Activation and the Development of Dopaminergic Neurotransmission of the Offspring: Relevance for Schizophrenia and Other Psychoses.
Aguilar-Valles A, Rodrigue B, Matta-Camacho E.
Front Psychiatry. 2020,
3) Defining a Canonical Ligand-Binding Pocket in the Orphan Nuclear Receptor Nurr1.
de Vera IMS, Munoz-Tello P, Zheng J, Dharmarajan V, Marciano DP, Matta-Camacho E, Giri PK, Shang J, Hughes TS, Rance M, Griffin PR, Kojetin DJ.
Structure. 2019,
4) Translational control of depression-like behavior via phosphorylation of eukaryotic translation initiation factor 4E.
Aguilar-Valles A, Haji N, De Gregorio D, Matta-Camacho E, Eslamizade MJ, Popic J, Sharma V, Cao R, Rummel C, Tanti A, Wiebe S, Nuñez N, Comai S, Nadon R, Luheshi G, Mechawar N, Turecki G, Lacaille JC, Gobbi G, Sonenberg N.
Nat Commun. 2018,
5) Translational control of ERK signaling through miRNA/4EHP-directed silencing.
Jafarnejad SM, Chapat C, Matta-Camacho E, Gelbart IA, Hesketh GG, Arguello M, Garzia A, Kim SH, Attig J, Shapiro M, Morita M, Khoutorsky A, Alain T, Gkogkas CG, Stern-Ginossar N, Tuschl T, Gingras AC, Duchaine TF, Sonenberg N.
Elife. 2018 ,
... and more -> https://pubmed.ncbi.nlm.nih.gov/?term=Matta-Camacho+Edna
Aguilar-Valles A, De Gregorio D, Matta-Camacho E, Eslamizade MJ, Khlaifia A, Skaleka A, Lopez-Canul M, Torres-Berrio A, Bermudez S, Rurak GM, Simard S, Salmaso N, Gobbi G, Lacaille JC, Sonenberg N.
Nature. 2021,
2) Maternal Immune Activation and the Development of Dopaminergic Neurotransmission of the Offspring: Relevance for Schizophrenia and Other Psychoses.
Aguilar-Valles A, Rodrigue B, Matta-Camacho E.
Front Psychiatry. 2020,
3) Defining a Canonical Ligand-Binding Pocket in the Orphan Nuclear Receptor Nurr1.
de Vera IMS, Munoz-Tello P, Zheng J, Dharmarajan V, Marciano DP, Matta-Camacho E, Giri PK, Shang J, Hughes TS, Rance M, Griffin PR, Kojetin DJ.
Structure. 2019,
4) Translational control of depression-like behavior via phosphorylation of eukaryotic translation initiation factor 4E.
Aguilar-Valles A, Haji N, De Gregorio D, Matta-Camacho E, Eslamizade MJ, Popic J, Sharma V, Cao R, Rummel C, Tanti A, Wiebe S, Nuñez N, Comai S, Nadon R, Luheshi G, Mechawar N, Turecki G, Lacaille JC, Gobbi G, Sonenberg N.
Nat Commun. 2018,
5) Translational control of ERK signaling through miRNA/4EHP-directed silencing.
Jafarnejad SM, Chapat C, Matta-Camacho E, Gelbart IA, Hesketh GG, Arguello M, Garzia A, Kim SH, Attig J, Shapiro M, Morita M, Khoutorsky A, Alain T, Gkogkas CG, Stern-Ginossar N, Tuschl T, Gingras AC, Duchaine TF, Sonenberg N.
Elife. 2018 ,
... and more -> https://pubmed.ncbi.nlm.nih.gov/?term=Matta-Camacho+Edna